GLUT12 offers a promising new therapeutic pathway due to its importance and role in breast cancer (Ismail and Tanasova, 2022) and Alzheimer’s disease (Gil-Iturbe et al., 2020). The gene discussed is SLC2A12; the disease is early-onset autosomal dominant Alzheimer disease.